Risk reduction

If you carry a BRCA mutation, you have options. The right choice is the one that is right for you.

Please note:

The information on this page is educational and general in nature. Your options depend on your specific mutation, age, family history, and personal circumstances. Please work closely with your medical team and genetic counsellor to determine the right path for you.

Ways to lower breast cancer risk

While breast cancer often occurs due to reasons out of one’s control including genetics, family history and breast density, according to research many breast cancers are attributable to potentially modifiable risk factors. 

Keep a healthy weight

Choose not to drink alcohol

Be physically active

Breastfeed your children, if possible

Enhanced surveillance

Enhanced surveillance does not reduce your risk of cancer, but it dramatically improves the chance of finding cancer early — when it is most treatable. For many carriers, this is the first pathway chosen.

Breast MRI

Annual MRI is the most sensitive screening tool for BRCA carriers. It is recommended from around age 25–30 for BRCA1 carriers and slightly later for BRCA2, in combination with mammography.

Mammogram & Ultrasound

Annual digital mammography, sometimes combined with ultrasound. Mammography is less sensitive in younger women with dense breast tissue, which is why MRI is usually added.

Gynaecological monitoring

Pelvic ultrasound and CA-125 blood tests may be offered for ovarian surveillance, though note that the evidence for their effectiveness is limited compared to breast screening.


Medication options

Certain medications have been shown to reduce breast cancer risk in high-risk women. These are sometimes called chemoprevention.

  • Tamoxifen — an oestrogen-blocker shown to reduce risk in pre-menopausal BRCA carriers by up to 50%. It is not suitable for everyone.

  • Raloxifene — used in post-menopausal women, similar mechanism to tamoxifen.

  • Aromatase inhibitors (e.g., exemestane) — another option for post-menopausal women in some studies.

These medications carry their own side effects and are not suitable for everyone. Your medical team can advise whether any are appropriate for you.

Surgical options

Surgery is the most effective way to reduce cancer risk for BRCA carriers. These are significant decisions that take time, reflection, and support — and they are entirely your choice.

Risk-reducing mastectomy

Removal of breast tissue reduces the risk of breast cancer by approximately 90–95%. Women may choose bilateral (both breasts) risk-reducing mastectomy. Reconstruction is usually available.

This is not the right choice for everyone, and should be considered after thorough discussion with a breast surgeon, plastic surgeon, and your psychological support team.

More information on reconstruction options

Risk-reducing salpingo-oophorectomy (RRSO)

Removal of the fallopian tubes and ovaries reduces ovarian cancer risk by approximately 80% and also reduces breast cancer risk in pre-menopausal women by lowering oestrogen levels.

This surgery induces surgical menopause and is typically recommended after a woman has completed her family, usually from around age 35–40 for BRCA1 and 40–45 for BRCA2.

Risk-reducing salpingectomy

Removal of the fallopian tubes only (while preserving the ovaries) is being studied as an interim option to reduce ovarian cancer risk while delaying menopause. This is an evolving area of research.

Discuss with your gynaecological oncologist whether this is an option for you.

Fertility & menopause considerations


Fertility preservation

If you are planning risk-reducing surgery that will end your fertility, speak with your medical team about fertility preservation options before proceeding. A fertility specialist can advise on what may be appropriate for your situation.

For support navigating fertility concerns within the Jewish community, you can contact the Australian Jewish Fertility Network — a dedicated support network for Jewish Australians facing fertility challenges. ajfn.org.au →

Managing surgical menopause

RRSO in pre-menopausal women causes immediate surgical menopause, which can bring significant symptoms: hot flushes, mood changes, bone loss, and cardiovascular changes. This does not need to be endured in silence.

  • Non-hormonal medications can help manage symptoms such as hot flushes and mood changes

  • Bone density monitoring is recommended

  • Regular cardiovascular health checks

Your gynaecologist or endocrinologist will help you manage this transition.